The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro
Although several clinical trials are now underway to test possible therapies, the worldwide response to the COVID-19 outbreak has been largely limited to monitoring/containment. We report here that Ivermectin, an FDA-approved anti-parasitic previously shown to have broad-spectrum anti-viral activity...
| Autor principal: | |
|---|---|
| Formato: | Other publications |
| Publicado: |
2020-04-03
|
| Materias: | |
| Acceso en línea: | https://doi.org/10.1016/j.antiviral.2020.104787 https://hdl.handle.net/20.500.12663/988 |